Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board


In June of this year, Dr Bożena Walewska-Zielecka was appointed to the Management Board of Medicover Sp. z o.o. and took over the post of Medical Director at Medicover. In her new role she will be responsible for medical quality, occupational medicine, prevention standards and the quality and risk management system, among others.

Dr Bożena Walewska-Zielecka became a new member of the Management Board of Medicover Sp. z o.o. At the same time, she assumed the position of Medical Director. Previously, she served as Deputy Clinical Director. She has been with Medicover since 1995.

The many years of experience gained at our company guarantees an excellent understanding of its functioning, priorities and key needs. Dr Bożena Walewska-Zielecka’s knowledge of Medicover combined with her medical and managerial experience will support the effective development of her department, 

comments Mirosław Suszek, Vice President of the Management Board, Director of Operations and Medical Division at Medicover Polska.

Bożena Walewska-Zielecka holds a PhD degree in medical sciences, is a pathologist, travel medicine physician and a specialist in liver disease. She also gained broad experience as a lecturer and researcher at Warsaw Medical University.
At the same time, Dr Piotr Soszyński took over the newly created position of Director of Medical Systems. He will be responsible for the maintenance and development of medical systems, supervising authorisations and access to the systems, as well as information security, including protecting medical information, along with the necessary adaptations to the new EU legal requirements, and cooperation with other innovation development teams.

Copy as a Plain Text


Related Stories
New Medicover Centre and Medicover Dentistry open in Warsaw's Wola district


A new Medicover Centre and Medicover Dentistry opened at Prosta 36 in Warsaw. The new location houses 28 doctors' offices and 4 dental offices. The Medicover Centre offers specialist consultations, diagnostic tests and occupational medicine services.
Planning a May weekend? Watch out for ticks


They are small and very inconspicuous, and their bite can cause serious diseases. Contrary to popular belief, we can find them not only in forests or meadows, but also in squares, city parks or near our homes. As experts stress, as many as 40 percent of ticks, as it’s them we’re talking about, can be carriers of dangerous bacteria and viruses that cause Lyme disease, babesiosis and tick-borne encephalitis. So if you’re planning a picnic, you should know how to protect yourself from them, what to do when a tick bites, and when to consult a doctor.
Medicover opens new dental centres in Wrocław and Szczecin


Medicover Dentistry is expanding its network with new branches in Szczecin and Wrocław. Increasing the number of dental offices is an important step towards expanding the dental services of Medicover Poland. This year alone, 27 new dental offices will join the network.
Experts: Adults should also be vaccinated against pertussis


Epidemiologists stress that in recent years we have been observing the return of infectious diseases, which for years have been considered to be under control or eradicated. One of them is pertussis, and its incidence has also been on the rise in Poland. This is confirmed by the data of the National Institute of Hygiene – in 2016, there were as many as 6,856 cases of the disease, while in 2017 there were slightly fewer – 3,034 [1]. Most vulnerable to the disease are young people between the ages of 10 and 14, adults and the elderly. According to experts, the most effective preventive measure continue to be vaccinations – mandatory for children, but also those recommended for adults who should take a booster dose every 10 years.

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.